Pregled bibliografske jedinice broj: 1175840
Beneficial effect of ACE inhibitors on kidney function in polycythemia vera
Beneficial effect of ACE inhibitors on kidney function in polycythemia vera // Wiener klinische Wochenschrift, 133 (2021), 15-16; 808-815 doi:10.1007/s00508-021-01812-3 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1175840 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Beneficial effect of ACE inhibitors on kidney
function in polycythemia vera
Autori
Krečak, Ivan ; Morić Perić, Martina ; Zekanović, Ivan ; Holik, Hrvoje ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko
Izvornik
Wiener klinische Wochenschrift (0043-5325) 133
(2021), 15-16;
808-815
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
angiotensin-converting enzyme inhibitors ; arterial hypertension ; hyperlipidemia ; renoprotection ; statins
Sažetak
Background: Reduced kidney function has been associated with worse clinical outcomes in patients with myeloproliferative neoplasms (MPN). Statins and angiotensin-converting enzyme inhibitors (ACE-i) have renoprotective properties and their pleiotropic effects might also affect the malignant MPN clone ; however, whether concomitant use of statins and ACE‑i has a positive effect on estimated glomerular filtration rate (eGFR) in polycythemia vera (PV) patients is currently unknown. Methods: This multicenter retrospective study investigated effects of statins and ACE‑i on 12-month eGFR dynamics in 75 PV patients. Results: Of the patients 25 (33.3%) had a 10% or more increase in eGFR at 12 months. Univariately, statins (55.5% vs. 16.3% ; p = 0.022), ACE‑i (61% vs. 24.6% ; p = 0.004), male sex (54.3%, vs. 15% ; p < 0.001) and the absence of chronic kidney disease (CKD, 45.5% vs. 16.1% ; p = 0.008) were statistically significantly associated with an improvement in eGFR. ACE‑i (p = 0.008), CKD (p < 0.001), male sex (p = 0.004) and higher baseline eGFR (p = 0.007) remained statistically significantly associated with an improvement in eGFR in the multivariate logistic regression model also including statins, hydroxyurea, high-risk disease, cardiovascular risk factors, chronic heart failure and baseline hematocrit. Conclusion: The ACE‑i might have renoprotective properties in PV. Further studies are needed to elucidate whether the use of these drugs could also affect other MPN-related outcomes.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Opća bolnica Šibenik,
Opća bolnica "Dr. Josip Benčević",
Klinička bolnica "Dubrava",
Opća bolnica Zadar
Profili:
Božena Coha
(autor)
Marko Lucijanic
(autor)
Velka Gverić-Krečak
(autor)
Hrvoje Holik
(autor)
IVAN KREČAK
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE